China Iguratimod Manufacturer, Supplier, Factory

Jiangsu Run'an Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd., a modern high-tech pharmaceutical company specializing in the R&D, production and sales of fertility regulation drugs and variety APIs. The project started construction in November 2018, covering an area of 59 mu, with a total investment of 160 million yuan and a total building area of about 25000 square meters.

Main Active pharmaceutical ingredient (API) products: Gemcitabine hydrochloride, Celecoxib, bromhexine hydrochloride, Iguratimod, Apremilast, Tofactinib Citrate, Crisaborole, Urapidil Hydrochloride, Sugammadex sodium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium bromide, Finerenone, Sodium risedronate, etc. We aim to become a world-class developer and manufacturer of reproductive products through constant improvement and innovation in technologies, and offer remarkable business opportunities to our partner companies worldwide. Our commitment to outstanding customer service has allowed us to forge solid relationships with our partners all over the world.